Public tenders in Central Asia: opportunity for European laboratories

Introduction to the public procurement market

Public tenders in Central Asia are a strategic channel for European pharmaceutical companies seeking international expansion. Uzbekistan, Kazakhstan, Kyrgyzstan and Turkmenistan have modernized procurement frameworks, focusing on quality, competitive pricing, and international compliance. Much of the region’s pharmaceutical demand is met through centralized procurement funded by health ministries, ensuring stable, high-volume contracts.

How procurement works in the region

Each country has specific features that must be understood:

1. Uzbekistan – priority for locally registered products, with exceptions in urgent health cases.

2. Kazakhstan – point-based evaluation valuing local content and prior tender experience.

3. Kyrgyzstan and Turkmenistan – more flexible procedures where pre-negotiations and institutional ties matter.

Key success factors:

• Competitive pricing without compromising quality.

• Strict adherence to delivery deadlines.

• Proper documentation adapted to local formats.

How ACIR supports European laboratories

ACIR Southern Europe provides end-to-end support, including:

1. Pre-analysis and selection of viable tenders.

2. Product registration and certification with local authorities.

3. Preparation of technical and financial proposals tailored to each country.

4. Logistics management and partnership with local distributors.

5. Post-award follow-up to ensure contract compliance.

This approach increases the chances of winning and helps build a solid reputation in the region.